# The Effectiveness of Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for Critically Ill Surgical Patients

> **NCT05458063** · — · COMPLETED · sponsor: **Wonju Severance Christian Hospital** · enrollment: 113 (actual)

## Conditions studied

- Surgery-Complications
- Acute Kidney Injury
- Critical Illness

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05458063
- **Lead sponsor:** Wonju Severance Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-25
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-06-10
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2024-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458063, "The Effectiveness of Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for Critically Ill Surgical Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05458063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*